INTRODUCTION
characteristic visual field deficits. By definition, it does not include elevated intraocular pressure (IOP) but it is known that elevated IOP is the key risk factor in the development of glaucoma 2, 3 . Raised IOP contributes to the optic nerve damage directly due to pressure effect and indirectly by reducing the blood supply to the optic nerve head to cause ischemia. One would therefore predict that the ideal drug to treat glaucoma would be a substance that lowers IOP, facilitates blood flow to the optic nerve head to prevent ischemia and neural cell death.
Different studies show that adenosine exert neuroprotection in the retina along with r e d u c i n g I O P b u t t h e r e s u l t s a r e inconclusive [4] [5] [6] [7] .
The available treatment modalities for ocular hypertension or glaucoma are pharmacological, laser and surgery 1, 2 . These modalities have their own advantages and disadvantages.
Considering the patient compliance, cost effectiveness and inherent risk of surgical management, pharmacological approach to reduce IOP appears to be the first choice of treatment. None of the existing agents singularly leads to adequate control of IOP.
The search for newer agents to treat glaucoma is an overwhelming clinical necessity.
The models of glaucoma in rabbits are well validated for their clinical correlation and have been used in numerous studies since their discovery 8, 9 .The field of glaucoma has not seen a new class of drugs since prostaglandin analogues was introduced more than a decade ago. Acknowledging that much research still needs to be done for other pharmacological options using different mechanism. In view of the above, the study was aimed to investigate the IOP reducing activity of adenosine in experimentally induced glaucoma model in rabbits.
METHODS
Healthy adult albino rabbits (New Zealand strain) of either sex, weighing 2-2.5 kg, housed in clean metallic cages in the standard laboratory conditions with free access to food and water ad-libitum were used in the study after obtaining approval from Institutional Animal Ethical Committee (IAEC).
Drugs and chemicals used were:- The mechanism of corticosteroid-induced ocular hypertension is increased aqueous outflow resistance 13 .The precise mechanism of how steroids cause elevation in IOP is not (Table 2) . Original Article Effects of Adenosine in Glaucoma; Shrestha R
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